비교리스트

 카트 문의
시장보고서
상품코드
1625440

란셋 시장 규모, 점유율, 동향, 산업 분석 보고서 : 유형별, 용도별, 거즈 사이즈별, 연령층별, 최종 사용자별, 지역별 - 시장 예측(2025-2034년)

Lancets Market Size, Share, Trends, Industry Analysis Report: By Type, Application, Gauze Size, Age Group, End User, and Region - Market Forecast, 2025-2034
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 128 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 란셋 시장 규모는 2034년까지 122억 3,000만 달러에 이를 것으로 예상됩니다. 이 보고서는 현재 시장 역학을 상세하게 통찰하고 미래 시장 성장에 대한 분석을 제공합니다.

통증을 최소화하는 기술과 자동 후퇴 기능과 같은 란셋 시장의 기술적 진보는 환자의 편안함과 안전성을 높일 수 있기 때문에 큰 동향이 되었습니다. 이러한 기술 혁신은 채혈 시 불편함을 줄이고 주사바늘 부상과 교차 오염과 같은 위험을 최소화합니다. 이러한 기능은 의료 종사자와 특히 당뇨병과 같은 만성 질환의 자체 모니터링을 수행하는 개인 간의 도입을 증가시키고 있습니다. 결과적으로 이러한 발전은 사용자 친화적인 설계를 지원하며보다 안전하고 효율적인 진단 도구에 대한 수요 증가에 부합합니다.

소아 의료와 노인 의료에 대한 주력은 이러한 특유의 요구에 따라 란셋 시장의 중요한 동향이 되고 있습니다. 바늘 크기가 작고 통증을 최소화하는 기능을 갖춘 맞춤형 란셋은 피부가 얇거나 상처를 입을 수 있는 소아와 노인 환자에게 편안함과 안전을 보장하도록 설계되었습니다. 이러한 목표를 좁힌 접근 방식은 건강 관리 환경 및 가정 관리에서 도입률을 높이고 환자 중심의 전문 진단 도구에 대한 수요가 증가함에 따라 시장 침투에 기여합니다.

란셋 시장 보고서 하이라이트

유형별로, 안전성이 강화되고 주사바늘 부상의 위험을 최소화하는 것이 중요하게 되었기 때문에 안전한 란셋 분야가 2024년 란셋 세계 시장의 매출 점유율을 선도했습니다.

란셋 시장의 헤모글로빈 검사 부문은 특히 영양 불량이 만연하고 있는 신흥국 지역에서 빈혈 유병률이 상승하고 주기적인 헤모글로빈 수치 모니터링이 필요하기 때문에 예측 기간 동안 가장 높은 CAGR을 나타낼 것으로 예상됩니다.

2024년에는 북미가 란셋 시장을 선도하고 있으며, 그 배경에는 견고한 헬스케어 인프라, 첨단 진단 기술의 보급, 정부 지원, 유리한 상환 정책이 있습니다.

아시아태평양 란셋 시장은 당뇨병 유병률 증가, 건강 관리 인식 증가, 자기 모니터링 장비 사용 증가로 인해 가장 높은 CAGR을 나타낼 것으로 예상됩니다.

B. Braun SE, Terumo Medical Corporation, Medline Industries, LP., AgaMatrix, F. Hoffmann-La Roche Ltd., ARKRAY, Inc., Owen Mumford Ltd., BD, Nipro Europe Group Companies, MTD Medical Technology and Devices, Astellas Pharma Inc. 등이 세계 주요 시장 기업입니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 란셋 시장 인사이트

  • 연령대 스냅샷
  • 란셋 시장 역학의 동향
    • 성장 촉진요인과 기회
      • 당뇨병 이환율의 상승과 자가 모니터링 유형의 도입 증가
      • 통증이 없는 란셋 수요 증가
    • 성장 억제요인과 과제
      • 란셋 관련 주사바늘 부상 감염의 발생률 증가
  • PESTEL 분석
  • 란셋 시장의 연령층별 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 란셋 시장 : 유형별

  • 주요 조사 결과
  • 소개
  • 안전 란셋
  • 표준 란셋
  • 수동으로 활성화
  • 자동 기동/압력 기동

제6장 세계의 란셋 시장 : 용도별

  • 주요 조사 결과
  • 소개
  • 포도당 검사
  • 헤모글로빈 검사
  • 응고 검사
  • 콜레스테롤 검사
  • 알레르기 검사
  • 신생아 검사
  • 기타 용도

제7장 세계의 란셋 시장 : 거즈 사이즈별

  • 주요 조사 결과
  • 소개
  • 22G 이하
  • 23G-33G
  • 33G 이상

제8장 세계의 란셋 시장 : 연령층별

  • 주요 조사 결과
  • 소개
  • 성인
  • 소아

제9장 세계 란셋 시장 : 최종 사용자별

  • 주요 조사 결과
  • 소개
  • 병원, 진료소, 외래수술센터(ASC)
  • 가정치료 환경
  • 기타 최종 사용자

제10장 세계의 란셋 시장 : 지역별

  • 주요 조사 결과
  • 소개
    • 란셋 시장 평가 : 지역(2020-2034년)
  • 북미
    • 북미 : 유형별(2020-2034년)
    • 북미 : 용도별(2020-2034년)
    • 북미 : 가제 사이즈별(2020-2034년)
    • 북미 : 연령층별(2020-2034년)
    • 북미 : 최종 사용자별(2020-2034년)
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 유형별(2020-2034년)
    • 유럽 : 용도별(2020-2034년)
    • 유럽 : 가제 사이즈별(2020-2034년)
    • 유럽 : 연령층별(2020-2034년)
    • 유럽 : 최종 사용자별(2020-2034년)
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 유형별(2020-2034년)
    • 아시아태평양 : 용도별(2020-2034년)
    • 아시아태평양 : 거즈 사이즈별(2020-2034년)
    • 아시아태평양 : 연령층별(2020-2034년)
    • 아시아태평양 : 최종 사용자별(2020-2034년)
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 유형별(2020-2034년)
    • 중동 및 아프리카 : 용도별(2020-2034년)
    • 중동 및 아프리카 : 가제 사이즈별(2020-2034년)
    • 중동 및 아프리카 : 연령층별(2020-2034년)
    • 중동 및 아프리카 : 최종 사용자별(2020-2034년)
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 유형별(2020-2034년)
    • 라틴아메리카 : 용도별(2020-2034년)
    • 라틴아메리카 : 가제 사이즈별(2020-2034년)
    • 라틴아메리카 : 연령층별(2020-2034년)
    • 라틴아메리카 : 최종 사용자별(2020-2034년)
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제11장 경쟁 구도

  • 확장 및 인수 분석
    • 확장
    • 인수
  • 파트너십/협업/계약/공개

제12장 기업 프로파일

  • B. Braun SE
  • Terumo Medical Corporation
  • Medline Industries, LP.
  • AgaMatrix
  • F. Hoffmann-La Roche Ltd
  • ARKRAY, Inc.
  • Oro Clean Chemie AG
  • BD.
  • Nipro Europe Group Companies
  • MTD Medical Technology and Devices
  • Astellas Pharma Inc.
KTH 25.02.03

The lancets market size is expected to reach USD 12.23 billion by 2034, according to a new study by Polaris Market Research. The report "Lancets Market Share, Size, Trends, Industry Analysis Report: By Type, Application, Gauze Size (22G and Below, 23G-33G, and Above 33G), Age Group, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Technological advancements in the lancets market, such as pain-minimizing technologies and automatic retraction features, have become a major trend due to their ability to enhance patient comfort and safety. These innovations reduce discomfort during blood sampling and minimize risks such as needle stick injuries and cross-contamination. Such features have led to increased adoption among healthcare professionals and individuals performing self-monitoring, particularly for chronic conditions such as diabetes. As a result, these advancements support user-friendly designs and align with the growing demand for safer and more efficient diagnostic tools.

Focusing on pediatric and geriatric care has become a significant lancets market trend due to the unique needs of the demographics. Tailored lancets with smaller needle sizes and pain-minimizing features are designed to ensure comfort and safety for children and elderly patients, who often have thinner or more fragile skin. This targeted approach increases adoption rates in healthcare settings and at-home care, contributing to market penetration as demand for specialized, patient-centric diagnostic tools grows.

Lancets Market Report Highlights

In terms of type, the safety lancets segment led the global lancets market revenue share in 2024 due to their enhanced safety features and the growing emphasis on minimizing the risk of needle-stick injuries.

The hemoglobin testing segment of the lancets market is anticipated to register the highest CAGR during the forecast period due to the rising prevalence of anemia, particularly in developing regions where malnutrition is more widespread, necessitating regular hemoglobin level monitoring.

In 2024, North America led the lancets market, driven by its robust healthcare infrastructure, widespread adoption of advanced diagnostic technologies, government support, and favorable reimbursement policies.

The Asia Pacific lancets market is expected to record the highest CAGR due to the rising prevalence of diabetes, increasing healthcare awareness, and growing use of self-monitoring devices.

B. Braun SE; Terumo Medical Corporation; Medline Industries, LP.; AgaMatrix; F. Hoffmann-La Roche Ltd; ARKRAY, Inc.; Owen Mumford Ltd.; BD; Nipro Europe Group Companies; MTD Medical Technology and Devices; and Astellas Pharma Inc. are a few global key market players.

Polaris Market Research has segmented the lancets market report on the basis of type, application, gauze size, age group, end user, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

  • Safety Lancets
  • Standard Lancets
  • Manually Activated
  • Push Button Lancets
  • Side Button Lancets
  • Automatically Activated/Pressure Activated

By Application Outlook (Revenue, USD Billion, 2020-2034)

  • Glucose Testing
  • Hemoglobin Testing
  • Coagulation Testing
  • Cholesterol Testing
  • Allergy Testing
  • Neonatal Testing
  • Other Applications

By Gauze Size Outlook (Revenue, USD Billion, 2020-2034)

  • 22G and Below
  • 23G-33G
  • Above 33G

By Age Group Outlook (Revenue, USD Billion, 2020-2034)

  • Adult
  • Pediatrics
  • By End User (Revenue, USD Billion, 2020-2034)
  • Hospitals, Clinics, and Ambulatory Surgery Centers
  • Homecare Settings
  • Other end users

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Lancets Market Insights

  • 4.1. Lancets Market - Age Group Snapshot
  • 4.2. Lancets Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Diabetes and Increasing Adoption of Self-Monitoring Types
      • 4.2.1.2. Increasing Demand for Painless Lancets
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Increasing Incidence of Lancet-related Needle stick Injuries Infections
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Lancets Market Age Group Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Lancets Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Lancets Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Safety Lancets
    • 5.3.1. Global Lancets Market, by Safety Lancets, by Region, 2020-2034 (USD Billion)
  • 5.4. Standard Lancets
    • 5.4.1. Global Lancets Market, by Standard Lancets, by Region, 2020-2034 (USD Billion)
  • 5.5. Manually Activated
    • 5.5.1. Global Lancets Market, by Manually Activated, by Region, 2020-2034 (USD Billion)
    • 5.5.2. Push Button Lancets
      • 5.5.2.1. Global Lancets Market, by Push Button Lancets, by Region, 2020-2034 (USD Billion)
    • 5.5.3. Side Button Lancets
      • 5.5.3.1. Global Lancets Market, by Side Button Lancets, by Region, 2020-2034 (USD Billion)
  • 5.6. Automatically activated/Pressure activated
    • 5.6.1. Global Lancets Market, by Automatically activated/Pressure activated, by Region, 2020-2034 (USD Billion)

6. Global Lancets Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Lancets Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Glucose Testing
    • 6.3.1. Global Lancets Market, by Glucose Testing, by Region, 2020-2034 (USD Billion)
  • 6.4. Hemoglobin Testing
    • 6.4.1. Global Lancets Market, by Hemoglobin Testing, by Region, 2020-2034 (USD Billion)
  • 6.5. Coagulation Testing
    • 6.5.1. Global Lancets Market, by Coagulation Testing, by Region, 2020-2034 (USD Billion)
  • 6.6. Cholesterol Testing
    • 6.6.1. Global Lancets Market, by Cholesterol Testing, by Region, 2020-2034 (USD Billion)
  • 6.7. Allergy Testing
    • 6.7.1. Global Lancets Market, by Allergy Testing, by Region, 2020-2034 (USD Billion)
  • 6.8. Neonatal Testing
    • 6.8.1. Global Lancets Market, by Neonatal Testing, by Region, 2020-2034 (USD Billion)
  • 6.9. Other Applications
    • 6.9.1. Global Lancets Market, by Other Applications, by Region, 2020-2034 (USD Billion)

7. Global Lancets Market, by Gauze Size

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
  • 7.3. 22G and Below
    • 7.3.1. Global Lancets Market, by 22G and Below, by Region, 2020-2034 (USD Billion)
  • 7.4. 23G-33G
    • 7.4.1. Global Lancets Market, by 23G-33G, by Region, 2020-2034 (USD Billion)
  • 7.5. Above 33G
    • 7.5.1. Global Lancets Market, by Above 33G, by Region, 2020-2034 (USD Billion)

8. Global Lancets Market, by Age Group

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Lancets Market, by Age Group, 2020-2034 (USD Billion)
  • 8.3. Adult
    • 8.3.1. Global Lancets Market, by Adult, by Region, 2020-2034 (USD Billion)
  • 8.4. Pediatrics
    • 8.4.1. Global Lancets Market, by Pediatrics, by Region, 2020-2034 (USD Billion)

9. Global Lancets Market, by End Users

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Lancets Market, by End Users, 2020-2034 (USD Billion)
  • 9.3. Hospitals, Clinics and Ambulatory Surgery Centers
    • 9.3.1. Global Lancets Market, by Hospitals, Clinics and Ambulatory Surgery Centers, by Region, 2020-2034 (USD Billion)
  • 9.4. Homecare Settings
    • 9.4.1. Global Lancets Market, by Homecare Settings, by Region, 2020-2034 (USD Billion)
  • 9.5. Other end users
    • 9.5.1. Global Lancets Market, by Other end users, by Region, 2020-2034 (USD Billion)

10. Global Lancets Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Lancets Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Lancets Market - North America
    • 10.3.1. North America: Lancets Market, by Type, 2020-2034 (USD Billion)
    • 10.3.2. North America: Lancets Market, by Application, 2020-2034 (USD Billion)
    • 10.3.3. North America: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
    • 10.3.4. North America: Lancets Market, by Age Group, 2020-2034 (USD Billion)
    • 10.3.5. North America: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.3.6. North America: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.3.7. Lancets Market - US
      • 10.3.7.1. US: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.3.7.2. US: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.3.7.3. US: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.3.7.4. US: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.3.7.5. US: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.3.8. Lancets Market - Canada
      • 10.3.8.1. Canada: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.3.8.2. Canada: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.3.8.3. Canada: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.3.8.4. Canada: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.3.8.5. Canada: Lancets Market, by End Users, 2020-2034 (USD Billion)
  • 10.4. Lancets Market - Europe
    • 10.4.1. Europe: Lancets Market, by Type, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Lancets Market, by Application, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Lancets Market, by Age Group, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.6. Lancets Market - UK
      • 10.4.6.1. UK: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.7. Lancets Market - France
      • 10.4.7.1. France: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.8. Lancets Market - Germany
      • 10.4.8.1. Germany: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.9. Lancets Market - Italy
      • 10.4.9.1. Italy: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.10. Lancets Market - Spain
      • 10.4.10.1. Spain: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.11. Lancets Market - Netherlands
      • 10.4.11.1. Netherlands: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.12. Lancets Market - Russia
      • 10.4.12.1. Russia: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.4.13. Lancets Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Lancets Market, by End Users, 2020-2034 (USD Billion)
  • 10.5. Lancets Market - Asia Pacific
    • 10.5.1. Asia Pacific: Lancets Market, by Type, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Lancets Market, by Application, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Lancets Market, by Age Group, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.6. Lancets Market - China
      • 10.5.6.1. China: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.7. Lancets Market - India
      • 10.5.7.1. India: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.8. Lancets Market - Malaysia
      • 10.5.8.1. Malaysia: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.9. Lancets Market - Japan
      • 10.5.9.1. Japan: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.10. Lancets Market - Indonesia
      • 10.5.10.1. Indonesia: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.11. Lancets Market - South Korea
      • 10.5.11.1. South Korea: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.12. Lancets Market - Australia
      • 10.5.12.1. Australia: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.5.13. Lancets Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Lancets Market, by End Users, 2020-2034 (USD Billion)
  • 10.6. Lancets Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Lancets Market, by Type, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Lancets Market, by Application, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Lancets Market, by Age Group, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.6.6. Lancets Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.6.7. Lancets Market - UAE
      • 10.6.7.1. UAE: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.6.8. Lancets Market - Israel
      • 10.6.8.1. Israel: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.6.9. Lancets Market - South Africa
      • 10.6.9.1. South Africa: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.6.10. Lancets Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Lancets Market, by End Users, 2020-2034 (USD Billion)
  • 10.7. Lancets Market - Latin America
    • 10.7.1. Latin America: Lancets Market, by Type, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Lancets Market, by Application, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Lancets Market, by Age Group, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.7.6. Lancets Market - Mexico
      • 10.7.6.1. Mexico: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.7.7. Lancets Market - Brazil
      • 10.7.7.1. Brazil: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.7.8. Lancets Market - Argentina
      • 10.7.8.1. Argentina: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Lancets Market, by End Users, 2020-2034 (USD Billion)
    • 10.7.9. Lancets Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Lancets Market, by Type, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Lancets Market, by Application, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Lancets Market, by Gauze Size, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Lancets Market, by Age Group, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Lancets Market, by End Users, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. B. Braun SE
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Terumo Medical Corporation
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Medline Industries, LP.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. AgaMatrix
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. F. Hoffmann-La Roche Ltd
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. ARKRAY, Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Oro Clean Chemie AG
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. BD.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Nipro Europe Group Companies
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. MTD Medical Technology and Devices
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Astellas Pharma Inc.
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제